Lombard Medical, Inc.
EVAR
EVAR was delisted on the 8th of November, 2017.
12 hedge funds and large institutions have $6.08M invested in Lombard Medical, Inc. in 2017 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 4 closing their positions.
14% less funds holding
Funds holding: 14 → 12 (-2)
37% less capital invested
Capital invested by funds: $9.64M → $6.08M (-$3.56M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$23.3K |
| 2 |
CB
Commerce Bank
Kansas City,
Missouri
|
+$5.21K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NLVP
New Leaf Venture Partners
New York
|
-$837K |
| 2 |
Renaissance Technologies
New York
|
-$22K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
-$21.1K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$14K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$5.09K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Invesco
Atlanta,
Georgia
| $3.48M | – | – | – |
|
|
A
2
Abingworth
London,
United Kingdom
| $1.81M | – | – | – |
|
|
SHI
3
SV Health Investors
Boston,
Massachusetts
| $701K | – | – | – |
|
|
4
Citadel Advisors
Miami,
Florida
| $25K | +$23.3K | +44,751 | New |
|
|
VKH
5
Virtu KCG Holdings
New York
| $21K | -$21.1K | -40,570 | -52% |
|
6
Goldman Sachs
New York
| $12K | -$165 | -316 | -1% |
|
7
Verition Fund Management
Greenwich,
Connecticut
| $11K | – | – | – |
|
8
HSBC Holdings
London,
United Kingdom
| $10K | – | – | – |
|
|
9
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $7K | -$5.09K | -9,774 | -43% |
|
|
CB
10
Commerce Bank
Kansas City,
Missouri
| $6K | +$5.21K | +10,000 | New |
|
11
UBS Group
Zurich,
Switzerland
| $4K | -$423 | -813 | -10% |
|
12
Morgan Stanley
New York
| $1K | – | – | – |
|
|
NLVP
13
New Leaf Venture Partners
New York
| – | -$837K | -1,072,634 | Closed |
|
|
14
Renaissance Technologies
New York
| – | -$22K | -27,734 | Closed |
|
|
15
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$14K | -18,526 | Closed |
|
EVAR Hedge Fund Activity: Q2 2017 in Review
12 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Lombard Medical, Inc. (EVAR) for Q2 2017, worth a combined $6.08M — down 37% from $9.64M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of EVAR and 2 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 0 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $23.3K. The largest seller was New Leaf Venture Partners, exiting entirely with an estimated $837K sold.
- 12 institutional investors held Lombard Medical, Inc. (EVAR) as of Q2 2017, down from 14 in Q1 2017.
- Funds reported $6.08M of Lombard Medical, Inc. stock for Q2 2017, down 37% quarter-over-quarter.
- 2 funds opened new Lombard Medical, Inc. positions in Q2 2017 and 4 closed out, a net change of -2 holders.
- The largest Lombard Medical, Inc. buyer in Q2 2017 was Citadel Advisors, an estimated $23.3K added.
- The largest Lombard Medical, Inc. seller in Q2 2017 was New Leaf Venture Partners, an estimated $837K sold.
Based on aggregated 13F filings for Q2 2017.